AN IDENTIFIED TETRAHYDROISOQUINOLINE FROM AYURVEDA MEDICINE, PROTECTS NIGROSTRIATAL DOPAMINERGIC NEURONS IN EXPERIMENTAL MODELS OF PARKINSON'S DISEASE

被引：0
|
作者：
Singh, R.
Sengupta, T.
Vinayagam, J.
Appukuttan, T. A.
Jaisankar, P.
Mohanakumar, K. P.
机构：
[1] CSIR, Indian Inst Chem Biol, Div Cell Biol, Kolkata, India
[2] CSIR, Indian Inst Chem Biol, Div Physiol, Kolkata, India
来源：
JOURNAL OF NEUROCHEMISTRY | 2011年 / 118卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TU05-08
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [31] Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson’s Disease
    Mohd. Moshahid Khan
    Syed Shadab Raza
    Hayate Javed
    Ajmal Ahmad
    Andleeb Khan
    Farah Islam
    Mohammed M. Safhi
    Fakhrul Islam
    Neurotoxicity Research, 2012, 22 : 1 - 15
  • [32] Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease
    Wi, Rayul
    Chung, Young Cheul
    Jin, Byung Kwan
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [33] Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson's Disease
    Khan, Mohd Moshahid
    Raza, Syed Shadab
    Javed, Hayate
    Ahmad, Ajmal
    Khan, Andleeb
    Islam, Farah
    Safhi, Mohammed M.
    Islam, Fakhrul
    NEUROTOXICITY RESEARCH, 2012, 22 (01) : 1 - 15
  • [34] Oestrogen and nigrostriatal dopaminergic neurodegeneration: Animal models and clinical reports of Parkinson's disease
    Liu, Bin
    Dluzen, Dean E.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (07) : 555 - 565
  • [35] Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
    Ingrid Morales
    Ricardo Puertas-Avendaño
    Alberto Sanchez
    Adrian Perez-Barreto
    Clara Rodriguez-Sabate
    Manuel Rodriguez
    Translational Neurodegeneration, 10
  • [36] Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
    Benner, EJ
    Mosley, RL
    Destache, CJ
    Lewis, TB
    Jackson-Lewis, V
    Gorantla, S
    Nemachek, C
    Green, SR
    Przedborski, S
    Gendelman, HE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) : 9435 - 9440
  • [37] Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease: removing axonal debris
    Morales, Ingrid
    Puertas-Avendano, Ricardo
    Sanchez, Alberto
    Perez-Barreto, Adrian
    Rodriguez-Sabate, Clara
    Rodriguez, Manuel
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [38] Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model
    Sawada, H
    Ibi, M
    Kihara, T
    Honda, K
    Nakamizo, T
    Kanki, R
    Nakanishi, M
    Sakka, N
    Akaike, A
    Shimohama, S
    NEUROPHARMACOLOGY, 2002, 42 (08) : 1056 - 1064
  • [39] Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera, Andrea
    Munoz, Patricia
    Steinbusch, Harry W. M.
    Segura-Aguilar, Juan
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (04): : 702 - 711
  • [40] ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
    C. Savio Chan
    Jaime N. Guzman
    Ema Ilijic
    Jeff N. Mercer
    Caroline Rick
    Tatiana Tkatch
    Gloria E. Meredith
    D. James Surmeier
    Nature, 2007, 447 : 1081 - 1086
12345